✦ LIBER ✦

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial

✍ Scribed by Karlsson, J. A.; Neovius, M.; Nilsson, J.-A.; Petersson, I. F.; Bratt, J.; van Vollenhoven, R. F.; Ernestam, S.; Geborek, P.

Book ID: 125546516
Publisher: BMJ Publishing Group
Year: 2012
Tongue: English
Weight: 532 KB
Volume: 72
Category: Article
ISSN: 0003-4967
DOI: 10.1136/annrheumdis-2012-202062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Addition of infliximab compared with add

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

✍ RF van Vollenhoven; S Ernestam; P Geborek; IF Petersson; L Cöster; E Waltbrand; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Ultrasonographic and radiographic result

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year–delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis

✍ P. C. Taylor; A. Steuer; J. Gruber; C. McClinton; D. O. Cosgrove; M. J. K. Bloml 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Treatment of rheumatoid arthritis with m

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two-year, randomized, double-blind, placebo-controlled trial

✍ James R. O'Dell; Robert Leff; Gail Paulsen; Claire Haire; Jack Mallek; P. James 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Combination therapy in early rheumatoid

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

✍ Dougados, M.; Combe, B.; Cantagrel, A.; Goupille, P.; Olive, P.; Schattenkirchne 📂 Article 📅 1999 🏛 BMJ Publishing Group 🌐 English ⚖ 209 KB

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Predictors of joint damage in patients w

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

✍ Josef S. Smolen; Désirée M. F. M. Van Der Heijde; E. William St.Clair; Paul Emer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB